There's no doubt that the consortium model is here to stay, but the challenge now is to avoid creating a bureaucracy of committees with duplicate missions and redundancies of effort. The answer might be a...

Biocartis spun out newco MyCartis (Lausanne, Switzerland), a combination of Pronota and Biocartis' Evalution unit, which was developing Biocartis' Evalution multiplex assay technology for protein and nucleic acid-based biomarker analysis. The technology was previously known...

Biocartis S.A. (Lausanne, Switzerland) raised EUR 64.5 million ($84.7 million) in an undisclosed venture round and separately spun out a newco, MyCartis, to develop the multiplex assay technology of Biocartis' Evalution business unit. The funding...

The EU awarded €6 million ($7.7 million) under its Seventh Framework Program (FP7) in research funding to the four-year Improved Pregnancy Outcomes via Early Detection (IMPROvED) consortium to develop a predictive preeclampsia diagnostic. The project,...

A validation study in 300 women showed that Pronota's mid-gestation preeclampsia screening test correctly identified 80% of women who developed preeclampsia that resulted in premature birth. The SCreening fOr Pregnancy Endpoints (SCOPE) Consortium compiled the...

Pronota N.V. , Zwijnaarde, Belgium   Business: Diagnostic, Pharmacogenetics   Hired: Carol Greve-Philips as CBO, formerly VP of corporate development at Genzyme Corp. , which Sanofi acquired; and Els Hubloux as CFO, formerly senior investment manager at...

Pronota and Mitsubishi Chemical Holdings' Molecuence Corp. subsidiary partnered to discover and validate protein biomarkers to diagnose stroke. Pronota will use its MASStermind protein biomarker discovery platform and MASSterclass protein biomarker verification tool. Further terms...

Pronota raised €1.5 million ($1.9 million) in a final close of a series B round, bringing the total raised in the round to €7.9 million. MedSciences Capital participated in the close. Pronota N.V. , Zwijnaarde, Belgium...

Pronota raised €1.3 million ($2 million) in an extension of a series B round, bringing the total raised to €6.2 million ($8.8 million). MP Healthcare Venture Management participated. The company raised €4.9 million ($6.9 million)...

Pronota N.V. , Zwijnaarde, Belgium   Business: Diagnostic, Pharmacogenetics   Date completed: 6/29/09   Type: Venture financing   Raised: €4.9 million ($6.9 million)   Investors: LSP-Life Sciences Partners; Gimv N.V.; Biotech Fund Flanders; KBC Private Equity;...